[go: up one dir, main page]

AU7406600A - A method of increasing the specificity of oxy-lna oligonucleotides - Google Patents

A method of increasing the specificity of oxy-lna oligonucleotides

Info

Publication number
AU7406600A
AU7406600A AU74066/00A AU7406600A AU7406600A AU 7406600 A AU7406600 A AU 7406600A AU 74066/00 A AU74066/00 A AU 74066/00A AU 7406600 A AU7406600 A AU 7406600A AU 7406600 A AU7406600 A AU 7406600A
Authority
AU
Australia
Prior art keywords
oxy
specificity
increasing
lna oligonucleotides
lna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74066/00A
Inventor
Mogens Havsteen Jakobsen
Alexei Koshkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exiqon AS
Original Assignee
Exiqon AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exiqon AS filed Critical Exiqon AS
Publication of AU7406600A publication Critical patent/AU7406600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/323—Chemical structure of the sugar modified ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU74066/00A 1999-10-04 2000-10-03 A method of increasing the specificity of oxy-lna oligonucleotides Abandoned AU7406600A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA199901421 1999-10-04
DKPA199901421 1999-10-04
US15772699P 1999-10-05 1999-10-05
US60157726 1999-10-05
DKPA200000973 2000-06-22
DKPA200000973 2000-06-22
PCT/DK2000/000549 WO2001025478A1 (en) 1999-10-04 2000-10-03 A method of increasing the specificity of oxy-lna oligonucleotides

Publications (1)

Publication Number Publication Date
AU7406600A true AU7406600A (en) 2001-05-10

Family

ID=27221281

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74066/00A Abandoned AU7406600A (en) 1999-10-04 2000-10-03 A method of increasing the specificity of oxy-lna oligonucleotides

Country Status (2)

Country Link
AU (1) AU7406600A (en)
WO (1) WO2001025478A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003093504A1 (en) * 2002-05-06 2003-11-13 Noxxon Pharma Ag Method for amplifying nucleic acids
CA2994089A1 (en) 2002-11-18 2004-06-03 Roche Innovation Center Copenhagen A/S Antisense gapmer oligonucleotides
AU2015204315B2 (en) * 2002-11-18 2017-06-22 Roche Innovation Center Copenhagen A/S Amino-LNA, thio-LNA and alpha-L-oxy-LN
WO2006043906A1 (en) * 2004-10-20 2006-04-27 Agency For Science, Technology And Research Method for resolving stereoisomers of a compound
ITMI20051050A1 (en) * 2005-06-07 2006-12-08 Roberto Sapio "METHOD FOR THE DETERMINATION OF SEQUENCES OF NUCLEIC AND ANALOGUE ACIDS"
EA201100810A1 (en) * 2006-04-03 2012-06-29 Сантарис Фарма А/С PHARMACEUTICAL COMPOSITION
CN101067133B (en) * 2007-04-12 2011-05-04 上海交通大学 Ligase independent gene cloning process based on thio-modification
WO2009039173A2 (en) 2007-09-19 2009-03-26 Applied Biosystems Inc. SiRNA SEQUENCE-INDEPENDENT MODIFICATION FORMATS FOR REDUCING OFF-TARGET PHENOTYPIC EFFECTS IN RNAi, AND STABILIZED FORMS THEREOF
KR101928418B1 (en) 2012-06-21 2018-12-12 미라젠 세러퓨틱스 인코포레이티드 Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif
MX2017009427A (en) 2015-01-20 2017-10-02 Miragen Therapeutics Inc Mir-92 inhibitors and uses thereof.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134066A (en) * 1989-08-29 1992-07-28 Monsanto Company Improved probes using nucleosides containing 3-dezauracil analogs
DE69829760T3 (en) * 1997-09-12 2016-04-14 Exiqon A/S BI- AND TRI-CYCLIC-NUCLEOSIDE, NUCLEOTIDE AND OLIGONUCLEOTIDE ANALOG

Also Published As

Publication number Publication date
WO2001025478A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
AU1387401A (en) Coating process
AU1854901A (en) Novel method
AU6032100A (en) New compounds
AU1538901A (en) Polymersation process
AU7406600A (en) A method of increasing the specificity of oxy-lna oligonucleotides
AU2833400A (en) Catalytic cracking process
AUPQ262599A0 (en) Gene expression
AU6853300A (en) Swage lining
AU6005000A (en) Polymerisation process
AU7273000A (en) Novel processes
AU1038501A (en) Novel processes
AU7461900A (en) Nucleotide sequences
AU1870000A (en) Gene therapy-2
AU6871900A (en) Tsg-like gene
AU5550700A (en) Novel process
AU1165801A (en) Novel process
AU6169100A (en) Novel process
AU5314999A (en) Modified oligonucleotides
AUPQ072899A0 (en) Denitrification process
AU2001257021A1 (en) Haplotypes of the cyp8b1 gene
AU7789000A (en) A method for the generation of repeat-depleted dna
AU2188401A (en) Assay method
AU5552200A (en) Method
AUPP888299A0 (en) Improved eduction process
AU5995900A (en) Novel process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase